Schizophrenia👻 Flashcards

(39 cards)

1
Q

Environmental risk factors

A

Prenatal problems
Obstetric complications
Urban / city birth
Stressful life events
Drug abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Genetic

A

Susceptibility genes (multiple genes involves in creating predisposition to developing the disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Schizophrenia common onset

A

Late adolescence/ early twenties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Positive symptoms

A

Hallucinations
Delusions
Disordered thoughts, speech and behaviour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Negative symptoms

A

Alogia
Affective flattening
Avolition
Anhedonia
Poverty of speech
Lack of motivation
Emotional flattening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cognitive symptoms

A

Attention deficit
Memory difficulties
Executive dyfunctioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dopamine hypothesis

A

Increase in dopamine in associative striatum > positive symptoms
Reduction in dopamine transmission in mesocortical pathway > cognitive symptoms
———————————————————————
Excessive DA release in striatum during illness exacerbations.
• Positively correlated with positive symptoms
• Correlated with good treatment response to antipsychotic drugs
• Inadequate DA in frontal cortex
• Associated with deficits in cognitive function e.g. working memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment Side effects (D2 blocker > antipsychotic)

A

Blocking dopamine in motor system (there was no problem with the dopamine in the motor system in schizophrenia) = Parkinsonial like side effects

Normally dopamine inhibits prolactin> treatment blocking D2 receptors = hyperprolactinaemia

Efficacy vs side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Typical & atypical antipsychotics

A

Antipsychotics are dopamine D2 receptor antagonists. The postsynaptic neurone think there’s normal levels of dopamine in that pathway.

Typical Antipsychotics (neuroleptics)
• e.g. Haloperidol, Chlorpromazine
• High affinity for dopamine D2 receptors

Atypical Antipsychotics (newer)
• e.g. Clozapine, Olanzapine, Risperidone
• Higher affinity for serotonin (5-HT2) than dopamine D2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Percentage blockade

A

Window of occupancy of D2 receptors needed in associative striatum is around 65% blockade to treat positive symptoms.
As you increase dose of antipsychotic , you increase blockage however side effects can also increase.
65%-70%, can begin to see hyperprolactinaemia. Narrow window of D2 occupancy between efficacy and raised prolactin. Some patients find this manageable.
78-80%+, extrapyramidal side effects. Keep blockade under this threshold (80%) so can maintain efficacy without these Parkinsonial side effects eg disrupted normal movement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is there too much dopamine in the brain in schizophrenia

A

Associative striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Receptors

A

Dopamine activates receptor on the post synaptic neurone. Some are D1 some are D2 receptors. D1 not affected in treatment . Antipsychotic blocks D2 receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dopamine and prolactin

A

Dopamine inhibits prolactin release. Increasing inhibition of D2 receptors through treatment )D2 receptor antagonists) increases prolactin. Hyperprolactinaemia. Narrow occupancy window. 65-70%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diagnosing

A

Investigate symptoms and if delusions are true or have any proof. Can you present proof of the opposite.
Symptoms of at least a month.
Psychosis not necessarily schizophrenia eg Illicit drugs can cause psychotic reactions/ dementia / depression
Signs of a problem for 6+ months
Repeat pattern of psychotic episodes overtime. Repeated episodes and durations important criteria.
Gather social, education, family, criminal justice, and medical history info
Prognosis important. The longer it’s left without treatment the worst it is long term.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ICC-11 and DSM-V diagnostic criteria

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antipsychotics and symptoms

A

They do not cure schizophrenia, they only ALLEVIATE symptoms
Work best when taken regularly. Poor adherence increases risk of relapse by 5 times.

17
Q

First episode schizophrenia

18
Q

Individual cognitive behavioural therapy for psychosis (CBTp)

A

Non pharmacological
In combination with drugs
Can be without antipsychotics but careful review required after a month in case necessary
Family interventions if possible to encourage support and relapse prevention (keeping out of hospital)
Advantage of working for positive, negative & cognitive symptoms (unlike antipsychotics mostly positive)
Arts therapies for negative symptoms
Connecting symptoms with behaviour

19
Q

First generation (typical) antipsychotics vs second generation (atypicals)

A

• First generation: sulpiride, flupenthixol, haloperidol, chlorpromazine, zuclopenthixol, trifluoperazine,
perphenazine
• Second generation: amisulpride, quetiapine, risperidone, olanzapine, clozapine, aripiprazole, paliperidone, lurasidone, asenapine
• LITTLE OR NO DIFFERENCE in effectiveness on symptoms. Need to focus side effects & contraindications eg
• Generally less extra-pyramidal side effects (EPSEs) and hyperprolactinaemia for second generation - with notable exceptions
• Metabolic side effects with second generation drugs - ‘metabolic syndrome’
• Antipsychotics have limited effects on negative and cognitive symptoms of schizophrenia
- This is important as these symptoms are correlated more closely with impairments in social/occupational functioning than positive symptoms

20
Q

Treatment

A

First episode schizophrenia:
Rule out other causes before diagnosis
Full social, physical, psychiatric, occupational and economical assessment
Offer antipsychotic therapy in conjunction with psychological interventions (individual CBT & family). Consider arts therapy for negative symptoms.
Choice of antipsychotic:
Partnership between patients
Views of carer also
Any antipsychotic history
Consider metabolic, EPSE, cardiovascular, hormonal and other side effects. Could they tolerate specific side effects over others?
Contraindications
Discuss illicit drug abuse / alcohol / smoking / OTC
Maintenance treatment:
May continue for 1-2 years if effective
Relapse risk high if stopped
Careful if withdrawing - slow
Consider depot (injectable antipsychotic as alternative to taking tablets everyday)

21
Q

Treatment of subsequent acute episodes

A

•Treat as first episode schizophrenia
• Review diagnosis and existing medications - adherence, adequate dose and duration, family, belief /stigma
•Consider the influence of substance misuse
•May need to switch therapy to alternative antipsychotic
•If already tried first generation drug, switch to second generation ‘atypical’ agent

Maintenance:
• If treatment is efficacious continue with regular review
• Inform patient high risk of relapse

Treatment resistant schizophrenia and clozapine:
•Offer clozapine if not responded adequately to treatment despite the sequential use of adequate doses of at least 2 different antipsychotics, one of which is a second generation ‘atypical’

22
Q

CORE principles using antipyschotic therapy

A

• Therapy should be prescribed on a trial basis, for 4-6 weeks at optimum dosage
• Record expected benefits and risks of treatment
• Inform patient that treatment may take 2-3 weeks to work
• Start at lower doses and titrate up according to tolerance/efficacy
• Record the rationale for continuing, changing or stopping medication
• Record the reason for high doses
• Patient-completed scales like
Glasgow Antipsychotic Side-Effect Scale (GASS) can help with monitoring or BEMIB (brief evaluation of medication influences and beliefs)

23
Q

Extra-pyramidal side effects (EPSEs) to antipsychotics

A

• EPSE’s are dose related and more likely to occur with typical antipsychotics
• However, higher doses of risperidone and amisulpride (atypical) can also cause EPSEs
• Generally speaking, there are 3 main treatments depending on the type of EPSE

Dystonia
• Muscle spasms in any part of the body, e.g. eye rolling, head/neck twisting swallowing problems
• Treat with anticholinergic or switch to atypical antipsychotic drug

Pseudo-Parkinsonism
Characterised by tremor, rigidity, bradykinesia
Treat by reducing the dose of antipsychotic, or by switching to an atypical drug
Can use anticholinergics short term, review 3/12

Akathisia
• Inner restlessness and desire/compulsion to move - shifting feet, pacing, crossing/uncrossing legs
• Treat by reducing the antipsychotic dose, or switching to an atypical drug
• Anticholinergics are not useful here
• Has been seen with aripiprazole

Tardive dyskinesia
Lip smacking/chewing, tongue protrusion
Approximately 50% of cases are not reversible
Anti-cholinergic drugs make it worse
Stop anticholinergics, reduce antipsychotic dose, withdraw antipsychotic and switch to atypical drug

24
Q

Side effects to antipsychotic: the metabolic syndrome

A

Increased weight , blood glucose and lipid profile
Can lead to obesity, diabetes, hyperlipidaemia , macro/microvascular diseases and death
Must monitor / screen carefully, use education / behavioural change, switch drugs if needed
Use statins and treatments for T2DM as required, orlistat and metformin useful for obesity
Most likely seen with clozapine, olanzapine, risperidone, paliperidone, quetiapine
Not likely with most typicals, amisulpride, aripiprazole, lurasidone, asenapine

25
Side effects to antipsychotics: hyperprolactinaemia
• All antipsychotics increase prolactin Dose related • Some asymptomatic, but should treat regardless due to effects on sexual function, breast growth/milk, amenorrhoea (lack of periods), breast cancer and BMD (bone mineral density) (osteoporosis) • Treat: switch to alternative or add aripiprazole • Some evidence for dopamine agonists but can worsen schizophrenia symptoms Most common with Risperidone, Paliperidone,, Amisulpride / sulpiride, Haloperidol Can add aripiprazole as it lowers prolactin but it is another antipsychotic so have to be careful
26
Side effects to antipsychotics: QT prolongation
• QT interval involves de and re-polarising of the heart for pumping action QT interval prolongation is a risk factor for ventricular arrhythmias and TdP Causes: • Some people have QT prolongation syndromes from birth • Drugs can also cause it: • Can be dose related and additive when >1 drug used • Other psychotropic/non-psychotropics implicated • ECGs essential, limits 440ms (men), 470ms (women) • If QT interval prolonged: switch/reduce dose and refer to cardiology!! Most common: Haloperidol, Quetiapine, Amisulpride
27
Other antipsychotic side effects
Anticholinergic effects, particularly clozapine and 1st generation typicals Photosensitivity - especially chlorpromazine (use sunscreen) Sedation - problem with most except aripiprazole, risperidone, amisulpride Neutropenia Postural hypotension and tachycardia (clozapine, quetipine) Lower seizure threshold (important for epileptics) Hyponatraemia • Neuroleptic malignant syndrome - rare but could be fatal Due to rapid changes in dopamine blockade (starting & stopping, changing etc) Watch out for rigidity, hyperthermia, tachycardia, sweating, fluctuating consciousness, raised Creatinine Kinase STOP antipsychotic and initiate specialist treatment
28
Monitoring antipsychotic therapy (NICE)
Regularly record response to treatment including changes in symptoms/behaviour • Regularly screen for and record management of side effects to antipsychotic treatment • Investigations for antipsychotic treatment (see also individual drug SmPCs) - Weight - Waist circumference - Pulse and BP - Fasting BMs and HbA1c - Lipids - Prolactin levels - Assessment of movement disorders, adherence nutrition and exercise - An ECG at baseline (only if specified in SmPC, personal history of CVD, inpatient admission or physical examination reveals CV risk factor (e.g. HTN)) • "The secondary care team (mental health team) should maintain responsibility for monitoring service users' physical health and the effects of antipsychotic medication for at least the first 12 months or until the person's condition has stabilised, whichever is longer. Thereafter, the responsibility for this monitoring may be transferred to primary care under shared care arrangements."
29
Depot (long acting) antipsychotic
Reduced hospitalisation and mortality Helps the adherence Stable levels When to use? • May be useful in cases where avoiding covert non-adherence is a priority • If the patient is refusing to take oral medication, explore preventable reasons first • Some patients may prefer to use depots: could support adherence in long term treatment BUT we must stress need to visit clinics or have home visits for injections Zuclopenthixol, flupentixol, haloperidol, fluphenazine (typicals - all decanoate) Olanzapine embonate, paliperidone palmitate, aripiprazole, risperidone (atypicals) • Little to choose between typical depots in efficacy • Possibly less EPSE with atypicals, but issues with risperidone and olanzapine • Start with a test dose for typicals (See Task on Blackboard) (has oil so may be allergy) • Start dose low and go slow • Injections into gluteal/deltoid muscle (See individual SmPCs) • Use longest possible dose interval - Paliperidone available as 3 monthly injections Cons: Some (eg risperadone) must be kept in the fridge so hard to administer & has delayed kinetics (takes a while to get into blood, weeks) Olanzapine has 1 in 1000 risk of severe overdose reaction (over sedated etc) so patients who get this must stay in clinic for 3hrs after
30
Combined/high dose antipsychotic treatment
Antipsychotic polypharmacy: more than one agent prescribed Very common • NICE: Do not initiate combined antipsychotic medication, except for short periods (eg, when changing medication) Limited evidence of benefit - Large increases in risk of side effects, drug-drug interactions and non-adherence • Cautious use of two drugs only advocated in treatment resistant illness, e.g. clozapine therapy augmented with another antipsychotic (e.g. amisulpride) (in severe illness) • HOWEVER - this assumption is now being questioned though not enough evidence to change practice at present
31
Clozapine
Used in treatment resistant schizophrenia Patient has already tried two other antipsychotics for sufficient duration and dose, one of which is atypical and still not had a response Lowers mortality significantly Reduces risk of suicide & death Titrate up. Retitration may also be needed from 0 if missed doses as suddenly going back to dose before can cause cardiovascular collapse and death. Three different brands, do not switch between them Monitoring needed to avoid neutropenia TASKS: • Danger symptoms and signs • Who can prescribe and dispense • What needs monitoring and how often • Dose titration (see right) • When to test clozapine plasma levels • Missed doses of clozapine - risks and what to do
32
Smoking & caffeine
• Many patients with mental illness smoke cigarettes - Nicotine may be a gateway to using other psychoactive substances • Benefits for mental health if patients do stop smoking, but timing important • Aromatic hydrocarbons (NOT NICOTINE) responsible for drug interactions. Not in NRT. - Induction of CYP1A2 - Clozapine, olanzapine, duloxetine, TCAs and benzodiazepine (BZD) levels fall by as much as 50% if smoking (haloperidol 20%) - On stopping smoking clozapine serum levels can increase by 50-72%. Really dangerous. - Levels take time to rise - Monitor levels and/or adjust dose accordingly • Caffeine also competes with clozapine at CYP1A2, causing clozapine levels to rise by 14-47% (lots of variability between individuals)(4-5 cups / day) - Excessive caffeine intake can cause restlessness, insomnia and may worsen psychosis - Caffeine also antagonises the effects of BZDs and 'Z drug' hypnotics Patients must report changes in smoking habit / caffeine intake
33
Clozapine adverse effects (EBL resources)
Metabolic syndrome Myocarditis Hypersalivation Neutropenia & agranulocytosis VE, sedation, infection Constipation
34
Medicines optimisation (summary)
• Patient advice for those with mental illness can be seen as a challenge • Non-pharmacological methods important treatment • Tailor drug treatment for schizophrenia to individual patient - Compare first generation 'typicals' with second generation 'aypicals' - Consider patient age, social history, metabolic and cardiovascular health • Prescribing advice: selecting and initiating the right treatment, do not delay clozapine if indicated • Education: depots do not guarantee adherence, minimise dual antipsychotic therapy, importance of monitoring • Patient advice: drug choice, initiation and important side effects
35
EBL Antipsychotics MOA & effect -Typical (e.g haloperidol, chlorpromazine) -Atypical (E.g clozapine, risperidone, olanzapine)
MOA: Typical antipsychotics are primarily D2 (dopamine) receptor antagonists. Leading to decreased dopamine neurotransmission. Atypical antipsychotics are D2 receptor antagonists plus effects on serotonin (5-HT2A, 5HT1, 5-HT2C) receptors. Newer second generation agents that produce fewer extrapyramidal actions Effects: Typical antipsychotics reduce dopaminergic neurotransmission, especially in the mesolimbic pathway. Atypical antipsychotics modulates both dopaminergic and serotonergic neurotransmission Other comments: Typical antipsychotics are used for symptom control. They have higher risk of extrapyramidal side effects (EPS). Atypical antipsychotics have a lower risk of EPS, but metabolic side effects. Also used for symptom control
36
EBL: Olanzapine
Ability to Cross the BBB (1 slide/minute) Chemical structure properties promoting BBB penetration: Lipophilic: Highly lipophilic – favours passive diffusion across lipid-rich BBB. Molecular weight: 312.4 g/mol – small enough (<400–500 Da) for passive transport. pKa = 7.4: Mostly non-ionised at physiological pH – enhances membrane permeability. Hydrogen bonding: Acceptors: 4 Donors: 1 (Well within the recommended max of 5 donors & 10 acceptors) Efflux transporter evasion: Not a significant substrate for P-glycoprotein – avoids being pumped out of CNS. 2. Pharmacology and Pathophysiology Justification (2 slides/minutes) Schizophrenia Pathophysiology: Linked to hyperdopaminergic activity in the associative striatum → causes positive symptoms (e.g. delusions, hallucinations). Negative symptoms may be due to serotonin-dopamine imbalance or prefrontal cortex dysfunction. Olanzapine Pharmacodynamics: Second-generation (atypical) antipsychotic. D2 receptor antagonist: Blocks dopamine in striatum. Reduces positive symptoms (e.g. delusions, hallucinations). 5HT2A receptor antagonist: Improves negative symptoms (e.g. withdrawal, flat affect). Reduces extrapyramidal side effects (compared to typical antipsychotics). Monitoring Requirements Baseline & ongoing monitoring includes: Metabolic monitoring: Weight/BMI & lipids: baseline, every 3 months (first year), then yearly. Fasting glucose: baseline, 1 month, then every 4–6 months. HbA1c: at 3 months, then annually. Vital signs: BP, pulse. Annual blood tests: FBC, LFTs, renal function (eGFR, urea, electrolytes). Mental health follow-up: adherence, side effects, response. CV risk assessment: at least annually. Relevant Patient Advice: Onset: May take days to weeks for therapeutic effect. Drowsiness: Caution with driving/operating machinery (especially early). Photosensitivity: Avoid prolonged sunlight at high doses. Administration: Orodispersible tablet can dissolve on tongue or be dispersed in water/milk/juice. Side effects: Report hypersomnia, appetite increase, sexual dysfunction. Missed dose: Take as soon as remembered unless near next dose – never double up. Overdose action: 111 if drowsy, abnormal movement, dizziness, gait issues. 999/A&E if seizures, breathing issues, irregular heartbeat. Lifestyle advice: Minimise alcohol, offer smoking cessation. ✅ Advantages Effective for positive symptoms – improves function and work attendance. Mood stabilisation & productivity increase. First-line treatment for schizophrenia (NICE guidelines). ❌ Disadvantages Adherence challenge – patient may resist taking medication. Metabolic side effects – weight gain, glucose intolerance. Not curative – symptom control only; long-term condition.
37
EBL: Haloperidol
1. Ability to Cross the BBB Key Molecular Properties of Haloperidol: Molecular weight: 375.9 Da ✅ (well under 500 Da) LogP: 3.7 ❌ (slightly above ideal range of 1.5–2.5, but still crosses BBB due to high lipophilicity) Hydrogen bond acceptors: 5 ✅ (≤10) Hydrogen bond donors: 1 ✅ (≤5) Polar surface area: 40.5 Ų ✅ (≤90 Ų) ✅ Conclusion: Haloperidol meets most BBB-crossing criteria and can efficiently pass through the lipid membrane despite a higher LogP. Pathophysiology of Schizophrenia: Mesolimbic pathway (D2 hyperactivity) → positive symptoms (e.g. hallucinations, delusions). Mesocortical pathway (D1 hypoactivity) → negative and cognitive symptoms. Haloperidol Pharmacology: Typical (first-gen) antipsychotic. Mechanism: Competitively blocks post-synaptic D2 receptors in the brain. Effect: Inhibits dopamine neurotransmission in mesolimbic pathway → reduces positive symptoms. High D2 binding affinity: Strong dopamine blockade for symptom control. 🧠 Note: Does not significantly help with negative or cognitive symptoms and may worsen them due to dopamine blockade in mesocortical areas. Monitoring and Follow-up Physical health: Weight, waist circumference, pulse, and blood pressure. Blood tests: Lipids, prolactin levels. Cardiac safety: Baseline ECG (due to QT prolongation risk). Dose strategy: Use lowest effective dose. Titrate gradually and review frequently. Relevant Patient Advice Adherence: Take exactly as prescribed. Missed dose: Take next scheduled dose, do not double up. Common side effects: Muscle stiffness or tension Drowsiness, dizziness → avoid driving or operating machinery Vision problems Low blood pressure → risk of falls Report worsening symptoms or serious side effects promptly. ✅ Advantages Effective in acute psychosis: Rapid control of positive symptoms. Multiple administration routes: Oral, intramuscular, intravenous. Titration flexibility: Individualised dosing possible. Cost-effective: Cheap and effective at low doses. Broad clinical use: Especially for emergency management. ❌ Disadvantages Extrapyramidal side effects (EPSEs): Tremors, rigidity, dystonia. QT prolongation: Risk of cardiac arrhythmias. Caution in elderly: Risk of cerebrovascular events (NICE guidance). Severe adverse effects: Neuroleptic Malignant Syndrome (NMS) Sedation and cognitive dulling
38
EBL: Later in the community, James is prescribed regular flupentixol decanoate depot injection 75mg monthly, after a short trial of oral therapy. The use of flupentixol depot was showing signs of improvement in James’ presentation of psychosis. However, a few months later James complains that his life is ‘messed up’ and that his relationship with his girlfriend has recently ended due to a ‘problem’. When asked about this, James appears reluctant to explain exactly what the ‘problem’ he is experiencing is. In response to James’ presentation above: a. Identify what may be happening to him, b. Describe the origins of James’ symptoms in relation to disease pathophysiology and relevant pharmacology, and c. Discuss management strategies that may help address his symptoms.
A. Likely Causes of Sexual Dysfunction Common side effect of flupentixol and other antipsychotics. Negative symptoms of schizophrenia (e.g. apathy, social withdrawal). Secondary depression. Emotional blunting as a side effect. Importance of a sensitive, non-judgmental conversation in a safe environment. B. Flupentixol – Mechanism & Sexual Dysfunction Mechanism of Action: Dopamine antagonist at D1 and D2 receptors (mesolimbic/mesocortical). Moderate 5HT2 antagonist – may help with negative symptoms. Depot formulation = long-acting, intramuscular injection. Mechanism of Sexual Dysfunction: D2 blockade in tuberoinfundibular pathway → ↑ prolactin → ↓ libido/arousal/orgasm. Hyperprolactinaemia is a key cause. Flupentixol is a prolactin-elevating antipsychotic (like haloperidol, risperidone). Other Common Side Effects: Fatigue, dry mouth, dizziness, constipation, insomnia. C. Management Strategies Assess medication adherence – missed doses can worsen side effects. Consider switching to aripiprazole (lower risk of sexual dysfunction). CBT or psychological support for coping and communication. Smoking cessation: 15+ cigarettes/day may induce CYP1A2, altering drug metabolism. Consider trial of sildenafil or tadalafil for erectile dysfunction (after risk assessment). ——————————————— A LIKELY TO BE Reduced libido (loss of sexual desire) and or Erectile dysfunction as is a common side effect of antipsychotic medication and in particular fllupentixol. Could also be.. Negative symptoms of schizophrenia (emotional withdrawal, apathy, reduced intrest in raltionships) Depressive symptoms as a secondary issue Other side effect from flupentixol, like emotional blunting wihc could affect his relationship It will be important to have an open and sensitive discussion with the pt in a safe environment, ensuring he is comfortable. B. Mechanism of action of flupentixol: Flupentixol is an antipsychotic medication which mainly functions as a dopamine receptor antagonist. It mainly blocks D2 receptors in the mesolimbic and mesocortical pathways but it is a powerful antagonist at both D1 and D2 receptors (unlike haloperidol-d2 antagonist only-extra info). It has less affinity at D3 and D4. By inhibiting these receptors, the medication reduces the intensity of the symptoms. Depot means it is administered intramuscularly and releases drug overtime, it is a long-acting antipsychotic. (In addition to its effects on dopamine receptors, Flupentixol decanoate also exhibits moderate antagonistic activity at serotonin (5-HT2) receptors. This dual action on both dopamine and serotonin receptors contributes to its antipsychotic efficacy and may mitigate some negative symptoms and cognitive deficits How does it cause the side effect of sexual dysfunction? The mechanism is mainly due to dopamine receptor antagonism which decreases the libido. Blockade of dopamine D2 receptors in the tuberoinfundibular pathway by antipsychotics may decrease the libido, impair arousal, and impair orgasm indirectly, by leading to elevated prolactin levels. Hyperprolactinemia is a major cause of sexual dysfunction and some antipsychotics like haloperidol,risperidone are classed as prolactin-elevating antipsychotics. Flupentixol is also under this class. Other side effects include fatigue,dry mouth, dizziness,constipation, insomnia etc C. Assess and ensure adherence Missed doses or poor adherence can contribute to worsening side effect Could consider an alternative medication like ariprazole, which is an atypical antipsychotic which has a lower risk for contributing to sexual dysfunction. Could also recoment the patient to attent CBT and other forms of counselling Tell the pt to consider smoking cessation as he smokes 15+ cigs a day which can impact metabolism of antipsychotic drugs by induceing cyp1a2. We could also consider trialing sildenafil or taladafil?
39
EBL Later, James needs to stop his flupentixol depot as it is no longer working for him. He also tries quetiapine and aripiprazole without much improvement in his symptoms. His consultant is now considering clozapine therapy for James. James says to you that he has read online that clozapine ‘is dangerous’ and that he is reluctant to take it without more information. · Summary of the clozapine adverse effect constipation, including strategies for patients to minimise risk from this adverse effect. · The impact of stopping/starting smoking and missing doses whilst taking clozapine with reference to drug blood levels and relevant patient advice. · Summary of the clozapine adverse effects neutropenia and agranulocytosis, including strategies for patients to minimise risk from these adverse effects.
Clozapine and Constipation Adverse Effect: Clozapine has potent anticholinergic properties → reduces gastrointestinal motility. Can lead to severe or life-threatening constipation, including bowel obstruction, paralytic ileus, and intestinal ischemia. Patient Risk Minimisation Strategies: Routine monitoring for bowel habits and signs of GI slowdown (e.g. abdominal pain, bloating, no bowel movement >48 hrs). Encourage: High-fibre diet Adequate hydration Regular physical activity Use stool softeners or laxatives prophylactically (e.g. lactulose or macrogols). Educate patient to report any changes early. Clozapine – Smoking, Dosing & Plasma Levels Smoking Impact: Smoking induces CYP1A2, the main enzyme metabolising clozapine. Starting smoking → ↓ plasma clozapine levels → reduced efficacy. Stopping smoking → ↑ plasma clozapine levels → increased risk of toxicity. Patient Advice: Inform prescriber immediately before any change in smoking status. May require dose adjustment if smoking habits change. Missed Doses: Clozapine has a narrow therapeutic window. Missing >48 hours of doses may lead to loss of tolerance → increased risk of seizures or myocarditis if restarted at full dose. Restart at lower dose and titrate slowly under supervision. Advice: Take doses consistently at the same time daily. Contact clinical team if doses are missed for over 48 hours. Neutropenia and Agranulocytosis Adverse Effect Summary: Life-threatening blood dyscrasias: Neutropenia: ↓ neutrophil count Agranulocytosis: near-total absence of granulocytes → high infection risk Risk highest in first 18 weeks of treatment. Risk Minimisation Strategies: Mandatory blood monitoring: Weekly for 18 weeks, then every 2 weeks until 1 year, then monthly if stable. Patient education to report: Sore throat, fever, flu-like symptoms. Do not initiate or continue without valid blood test result. Clozapine should be immediately stopped if neutrophil count drops below safe threshold.